Galapagos NV Asset Resilience Ratio

Latest as of March 2026: 86.45%

Galapagos NV asset resilience ratio. Galapagos NV (GXEA) has an Asset Resilience Ratio of 86.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GXEA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€2.92 Billion

≈ $3.41 Billion USD Cash + Short-term Investments

Total Assets

€3.37 Billion

≈ $3.94 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Galapagos NV (2019–2025)

Asset resilience ratio of Galapagos NV from 2019 to 2025. This chart shows how Galapagos NV's Asset Resilience Ratio has changed over time. Read debt load of Galapagos NV for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Galapagos NV's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Galapagos NV.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.92 Billion	86.45%
Total Liquid Assets	€2.92 Billion	86.45%

Asset Resilience Insights

Very High Liquidity: Galapagos NV maintains exceptional liquid asset reserves at 86.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Galapagos NV Industry Peers by Asset Resilience Ratio

Compare Galapagos NV's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Galapagos NV Asset Resilience Ratio by Year (2019–2025)

Galapagos NV asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Galapagos NV.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	85.43%	€2.91 Billion ≈ $3.40 Billion	€3.41 Billion ≈ $3.98 Billion	+11.60pp
2024-12-31	73.83%	€3.05 Billion ≈ $3.57 Billion	€4.14 Billion ≈ $4.84 Billion	-6.90pp
2023-12-31	80.73%	€3.52 Billion ≈ $4.11 Billion	€4.36 Billion ≈ $5.09 Billion	+4.99pp
2022-12-31	75.74%	€3.59 Billion ≈ $4.19 Billion	€4.73 Billion ≈ $5.53 Billion	+28.18pp
2021-12-31	47.56%	€2.47 Billion ≈ $2.89 Billion	€5.19 Billion ≈ $6.07 Billion	-5.37pp
2020-12-31	52.93%	€3.03 Billion ≈ $3.54 Billion	€5.72 Billion ≈ $6.68 Billion	-11.65pp
2019-12-31	64.58%	€3.92 Billion ≈ $4.58 Billion	€6.07 Billion ≈ $7.09 Billion	--

pp = percentage points

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$2.22 Billion

€1.90 Billion EUR

Market Cap Rank

#6740 Global

#991 in Germany

Share Price

€28.80

Change (1 day)

+0.00%

52-Week Range

€22.40 - €29.20

All Time High

€246.00